Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apixaban in recent acute coronary syndrome
NCT00831441Phase 3Terminated
- Sponsor
- Bristol Myers Squibb
- Start
- Mar 2009
- Primary completion
- Mar 2011
- Modality
- Small Molecules
- Countries
- 40
01
Overview
A Phase 3 trial of apixaban in acute coronary syndrome (ACS), sponsored by Bristol Myers Squibb. Started Mar 2009; status: terminated.
02
Drugs
apixaban
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT00831441.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00831441.